Showing results (331-340 of 1,349) with videos related to
Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|November 11, 2017
Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration ConditionsHelen S Pentikis, Nikki AdetoroClinical Pharmacology in Drug Development|May 30, 2020
Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single-Dose and Multiple-Ascending-Dose Phase 1 Studies in Healthy AdultsIshani Landry, Kenya Nakai, Jim Ferry, et al.Clinical Pharmacology in Drug Development|May 1, 2021
Evaluation of the Effects of Repeat-Dose Dabrafenib on the Single-Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate)Noelia Nebot, Christina S Won, Victor Moreno, et al.Clinical Pharmacology in Drug Development|May 4, 2021
Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN-812 (Viloxazine Extended-Release) Pharmacokinetics in Healthy AdultsZhao Wang, Alisa R Kosheleff, Lilian W Adeojo, et al.Clinical Pharmacology in Drug Development|May 5, 2021
A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy SubjectsChing Thai, Bola Tayo, David CritchleyClinical Pharmacology in Drug Development|June 25, 2020
Effect of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intravenous RivipanselBrinda K Tammara, Kelly Ryan, Anna Plotka, et al.Clinical Pharmacology in Drug Development|May 17, 2020
Effect of Opicapone Tablets on Levodopa and 3-O-Methyldopa Pharmacokinetics in Healthy Japanese Subjects: Phase 1 StudyMasahiro Nomoto, Atsushi Takeda, Katsuaki Iwai, et al.Clinical Pharmacology in Drug Development|May 27, 2020
Application of a Backpropagation Artificial Neural Network in Predicting Plasma Concentration and Pharmacokinetic Parameters of Oral Single-Dose Rosuvastatin in Healthy SubjectsYichao Xu, Honggang Lou, Jinliang Chen, et al.Clinical Pharmacology in Drug Development|May 28, 2020
Population Pharmacokinetics and Exposure-Response Analysis of nab-Paclitaxel in Pediatric Patients With Recurrent or Refractory Solid TumorsYan Li, Nastya Kassir, Nianhang Chen, et al.Clinical Pharmacology in Drug Development|May 21, 2020
Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese SubjectsHaiyan Li, Weijiang Zhang, Claire Petry, et al.Pageof 135